Cannabis legislation opens the door for pharmaceutical brands in Brazil
With new legislation regulating the use of cannabis-based medicines in Argentina and Brazil, the emerging market is an open playing field for pharmaceutical brands looking to making a mark in Latin America.
Daniela Lin